Search results
Results from the WOW.Com Content Network
Following is a list of antipsychotics, ... Seroquel: dibenzothiazepine: N05AH04 Remoxipride: ... Generic Name Brand Names Chemical class
Maybe some research about the exclusivity status of Seroquel XR should be done. The "Dosage" section mentions 2017 as the year of expiration of such exclusivity. However, I just got my refill for 150mg tablets, and got a Generic made by Teva, and named Teva Quetiapine XR. Update: Here are some links about the subject.
During its 2007 Q2 earnings conference, AstraZeneca announced plans to launch Seroquel XR in the U.S. during August 2007. [91] However, Seroquel XR has become available in U.S. pharmacies only after the FDA approved Seroquel XR for use as maintenance treatment for schizophrenia, in addition to acute treatment of the illness, on 16 November 2007 ...
While the pharmaceutical space has been generating hefty returns for investors since the start of the year, shares of Teva Pharmaceuticals are up a mere 2.7%. Compare that with Dow component ...
Teva is in the process of recovering from loss of exclusivity to its multiple sclerosis drug Copaxone and a spate of lawsuits, and is betting that a trio of its branded drugs - Austedo, migraine ...
The FDA has pulled Teva Pharmaceuticals' (NYS: TEVA) generic version of antidepressant drug Wellbutrin from the market. The issue is not one of safety, but efficacy, as Teva's 300mg generic fails ...
Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing ...
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...